Edition:
United States

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

16.48EUR
21 Aug 2018
Change (% chg)

-- (--)
Prev Close
€16.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
171,173
52-wk High
€16.85
52-wk Low
€10.02

Chart for

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.75
Market Cap(Mil.): €1,145.42
Shares Outstanding(Mil.): 71.84
Dividend: 0.10
Yield (%): 0.43

Financials

  FAGRO.BR Industry Sector
P/E (TTM): 26.35 28.28 30.39
EPS (TTM): 0.62 -- --
ROI: 9.18 12.94 12.61
ROE: 26.14 14.96 14.80

BRIEF-Fagron Reports Q1 Turnover At 109.1 Million Euros

* Q1 TURNOVER EUR 109.1 MILLION VERSUS EUR 109.0 MILLION YEAR AGO

Apr 12 2018

French and Benelux stocks-Factors to watch on April 4

April 4 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Apr 04 2018

BRIEF-Humco And Fagron To Combine For Up To 70 Million Dollars

* ‍GREGORY PULIDO, HUMCO'S CHAIRMAN AND CHIEF EXECUTIVE OFFICER, WILL TRANSITION TO ROLE OF EXECUTIVE CHAIRMAN​

Apr 03 2018

BRIEF-Fagron Acquires Humco in United States

* FAGRON STRENGTHENS STRATEGIC POSITION IN USA THROUGH HIGHLY COMPLEMENTARY ACQUISITION OF HUMCO

Apr 03 2018

Earnings vs. Estimates